MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Role of the other babinski sign in hemifacial spasm

YC. Chen, SL. Chen (Taichung, Taiwan)

Meeting: 2025 International Congress

Keywords: Blepharospasm, Botulinum toxin: Clinical applications: other, Hemifacial spasm(HFS)

Category: Non-Dystonia (Other)

Objective: To investigate the role of the “Other Babinski Sign” in differentiating HFS from blepharospasm and to determine its prevalence in HFS patients.

Background: The “Other Babinski Sign”, described by Joseph Babinski in 1905, is characterized by simultaneous eye closure and eyebrow elevation. (Figure 1) This sign is valuable for diagnosing Hemifacial Spasm (HFS) but is often under-recognized.

Method: We enrolled 142 patients with HFS and 105 patients with blepharospasm at a botulinum toxin clinic. The diagnosis of HFS was based on the presence of unilateral involuntary facial muscle contractions affecting at least one or more areas innervated by the ipsilateral facial nerve, while all blepharospasm patients exhibited bilateral contractions of the periorbital muscles. We assessed the Other Babinski Sign in consecutive patients attending the clinic and re-evaluated them approximately three to four months after their last treatment. We also compared response rates (self-reported improvement of over 50%) to botulinum toxin injections between HFS patients with and without the sign.

Results: Among the 142 HFS patients (97 females, 45 males; mean age: 66.93 years old), 113 (79.6%) exhibited the Other Babinski Sign, while it was absent in all 105 blepharospasm patients (81 females, 24 males; mean age: 66.7 years old). In female patients with HFS, 80 (82.5%) patients showed the sign, compared to 33 (73.3%) patients in males. (Table 1)

    Response rates to botulinum toxin treatment were similar: 98/113 (86.7%) in HFS patients with the sign and 25/29 (86.2%) in those without the sign. There is no significant difference between these two groups.

Conclusion: Our findings confirm that the Other Babinski Sign is a useful diagnostic tool for HFS. Increasing awareness among neurologists may lead to earlier diagnosis and timely transfer to movement disorder specialists for appropriate treatment.

[table1]

[table1]

[figure1]

[figure1]

References: Sara Varanda, Sofia Rocha, Margarida Rodrigues, Álvaro Machado, Gisela Carneiro, Role of the “other Babinski sign” in hyperkinetic facial disorders,
Journal of the Neurological Sciences, Volume 378,2017, Pages 36-37

To cite this abstract in AMA style:

YC. Chen, SL. Chen. Role of the other babinski sign in hemifacial spasm [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/role-of-the-other-babinski-sign-in-hemifacial-spasm/. Accessed October 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/role-of-the-other-babinski-sign-in-hemifacial-spasm/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley